Major depressive disorder affects a substantial number of individuals worldwide and may not respond to standard oral antidepressants. In such instances, clinicians can explore alternative therapies tailored for individuals whose depression persists despite multiple medication trials. Spravato treatment offers a new pathway for those with treatment-resistant depression.
What Is Depression?
Depression is characterized by persistent changes in mood, thoughts, and physical health, negatively influencing those who are afflicted with it. The severity and combination of these symptoms can vary among individuals, but their impact frequently disrupts daily living and interpersonal relationships. Common symptoms include:
- Ongoing sadness
- Loss of interest or pleasure in activities
- Diminished energy or excessive fatigue
- Difficulty concentrating
- Significant changes in appetite or weight
- Sleep disturbances, including insomnia or hypersomnia
- Feelings of worthlessness or excessive guilt
- Recurrent thoughts of death or self-harm
Accurate diagnosis requires assessment by a licensed mental health provider.
What Is Spravato?
Spravato is an intranasal formulation of esketamine that is approved for the management of adults with treatment-resistant depression. Unlike traditional antidepressants, which primarily influence serotonin, norepinephrine, or dopamine, Spravato targets the glutamate neurotransmitter system. Esketamine aims to support the restoration of neural pathways involved in mood regulation. Access to Spravato is strictly regulated to promote safe use, and only trained clinicians can provide and supervise this medication.
What Should You Expect From Spravato Treatment?
Spravato treatment requires structured protocols and is conducted under routine supervision by medical professionals. Each session occurs at a healthcare facility, designated for this purpose. The general process involves the following steps:
- Self-administration: Under direct observation, you self-administer the nasal spray as directed by your provider.
- Monitoring: After receiving the medication, you remain under clinical supervision in a dedicated observation area for at least two hours.
- Post-session: Due to the risk of drowsiness or slowed reaction times, you are required to arrange transportation from the clinic and must not drive for the rest of the day.
Treatment schedules typically start with two sessions per week for four weeks. If your healthcare provider determines that you are responding positively, frequency can be reduced. Your response to therapy and any emerging side effects are monitored during regular appointments, and clinicians may adjust the treatment plan as needed. Potential side effects can include dissociation or dizziness. Your healthcare team will provide guidance on what to expect and address any questions about safety and adverse effects.
Comprehensive depression management often includes multiple strategies. Psychotherapy may be used alongside medication to help you develop skills for managing symptoms and addressing underlying thought patterns. Medical teams specializing in psychiatric care are equipped to offer individualized support, coordinating between therapeutic modalities.
Seek Professional Medical Oversight
Spravato presents a unique intervention for treatment-resistant depression, requiring both careful screening and ongoing clinical supervision. A medical evaluation prior to starting Spravato may include a thorough review of your health history, diagnoses, current medications, and any potential conditions that increase risks associated with treatment. Choosing a mental health treatment like Spravato is a decision best made with the guidance of a qualified medical professional. Collaboration with your care team supports safe access to all available treatment options and provides structure for short-term relief and long-term recovery.